Product References
Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa.
American journal of human genetics
Davidson AE,Schwarz N,Zelinger L,Stern-Schneider G,Shoemark A,Spitzbarth B,Gross M,Laxer U,Sosna J,Sergouniotis PI,Waseem NH,Wilson R,Kahn RA,Plagnol V,Wolfrum U,Banin E,Hardcastle AJ,Cheetham ME,Sharon D,Webster AR
Thu Aug 08 00:00:00 UTC 2013
Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa.
American journal of human genetics
Davidson AE,Schwarz N,Zelinger L,Stern-Schneider G,Shoemark A,Spitzbarth B,Gross M,Laxer U,Sosna J,Sergouniotis PI,Waseem NH,Wilson R,Kahn RA,Plagnol V,Wolfrum U,Banin E,Hardcastle AJ,Cheetham ME,Sharon D,Webster AR
Thu Aug 08 00:00:00 UTC 2013
Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa.
American journal of human genetics
Davidson AE,Schwarz N,Zelinger L,Stern-Schneider G,Shoemark A,Spitzbarth B,Gross M,Laxer U,Sosna J,Sergouniotis PI,Waseem NH,Wilson R,Kahn RA,Plagnol V,Wolfrum U,Banin E,Hardcastle AJ,Cheetham ME,Sharon D,Webster AR
Thu Aug 08 00:00:00 UTC 2013
Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa.
American journal of human genetics
Davidson AE,Schwarz N,Zelinger L,Stern-Schneider G,Shoemark A,Spitzbarth B,Gross M,Laxer U,Sosna J,Sergouniotis PI,Waseem NH,Wilson R,Kahn RA,Plagnol V,Wolfrum U,Banin E,Hardcastle AJ,Cheetham ME,Sharon D,Webster AR
Thu Aug 08 00:00:00 UTC 2013
BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
Neoplasia (New York, N.Y.)
Taniuchi K,Yokotani K,Saibara T
Tue May 01 00:00:00 UTC 2012
BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
Neoplasia (New York, N.Y.)
Taniuchi K,Yokotani K,Saibara T
Tue May 01 00:00:00 UTC 2012
BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
Neoplasia (New York, N.Y.)
Taniuchi K,Yokotani K,Saibara T
Tue May 01 00:00:00 UTC 2012
BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
Neoplasia (New York, N.Y.)
Taniuchi K,Yokotani K,Saibara T
Tue May 01 00:00:00 UTC 2012
BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7.
PloS one
Taniuchi K,Yokotani K,Saibara T
Fri Aug 03 00:00:00 UTC 2012
BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7.
PloS one
Taniuchi K,Yokotani K,Saibara T
Fri Aug 03 00:00:00 UTC 2012
BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7.
PloS one
Taniuchi K,Yokotani K,Saibara T
Fri Aug 03 00:00:00 UTC 2012
BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7.
PloS one
Taniuchi K,Yokotani K,Saibara T
Fri Aug 03 00:00:00 UTC 2012
Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.
Cancer research
Taniuchi K,Nishimori I,Hollingsworth MA
Tue Feb 01 00:00:00 UTC 2011
Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.
Cancer research
Taniuchi K,Nishimori I,Hollingsworth MA
Tue Feb 01 00:00:00 UTC 2011
BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
International journal of oncology
Taniuchi K,Iwasaki S,Saibara T
Tue Nov 01 00:00:00 UTC 2011
BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
International journal of oncology
Taniuchi K,Iwasaki S,Saibara T
Tue Nov 01 00:00:00 UTC 2011
BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
International journal of oncology
Taniuchi K,Iwasaki S,Saibara T
Tue Nov 01 00:00:00 UTC 2011
BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
International journal of oncology
Taniuchi K,Iwasaki S,Saibara T
Tue Nov 01 00:00:00 UTC 2011
BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
International journal of oncology
Taniuchi K,Iwasaki S,Saibara T
Tue Nov 01 00:00:00 UTC 2011
BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
International journal of oncology
Taniuchi K,Iwasaki S,Saibara T
Tue Nov 01 00:00:00 UTC 2011
Truncation mutation in HRG4 (UNC119) leads to mitochondrial ANT-1-mediated photoreceptor synaptic and retinal degeneration by apoptosis.
Investigative ophthalmology & visual science
Mori N,Ishiba Y,Kubota S,Kobayashi A,Higashide T,McLaren MJ,Inana G
Sat Apr 01 00:00:00 UTC 2006
Truncation mutation in HRG4 (UNC119) leads to mitochondrial ANT-1-mediated photoreceptor synaptic and retinal degeneration by apoptosis.
Investigative ophthalmology & visual science
Mori N,Ishiba Y,Kubota S,Kobayashi A,Higashide T,McLaren MJ,Inana G
Sat Apr 01 00:00:00 UTC 2006
Truncation mutation in HRG4 (UNC119) leads to mitochondrial ANT-1-mediated photoreceptor synaptic and retinal degeneration by apoptosis.
Investigative ophthalmology & visual science
Mori N,Ishiba Y,Kubota S,Kobayashi A,Higashide T,McLaren MJ,Inana G
Sat Apr 01 00:00:00 UTC 2006
Truncation mutation in HRG4 (UNC119) leads to mitochondrial ANT-1-mediated photoreceptor synaptic and retinal degeneration by apoptosis.
Investigative ophthalmology & visual science
Mori N,Ishiba Y,Kubota S,Kobayashi A,Higashide T,McLaren MJ,Inana G
Sat Apr 01 00:00:00 UTC 2006